Human Mast Cell Line (LUVA)

Immortalized Human Mast Cell Line (LUVA) that is easily cultured without growth factors and expresses FceRI for investigating inflammation response.


  • Fast growing and increased life span, compared to typical blood-derived CD34+ cells
  • Proliferate independent of exogenous stem cell factors
  • Contain granules and express high levels of mast cell cytokines, prostaglandins and leukotrienes

Mast cells exist in several types of tissues and play a role in allergy and anaphylaxis as a factor in inflammation response. They are also involved in wound healing and defense against pathogens. These cells express the high-affinity receptors that are specific to IgE, FceRI, on their surface, making IgE molecules cell-surface receptors for an antigen. When bound IgE molecules find a substrate, mast cells release inflammatory mediators like histamine.

From the laboratory of John W. Steinke, PhD, Larry C. Borish, MD, and S. Brandon Early, University of Virginia.

The Investigator's Annexe Part of The Investigator's Annexe program.

Catalog Number Product Size AVAILABILITY Price Qty
Human Mast Cell Line (LUVA), 1 vial
1 vial In stock
Price: $999.00

This product is for sale to Nonprofit customers only. For profit customers, please Contact Us for more information.

Product Type: Cell Line
Name: Human Mast Cell Line (LUVA)
Cell Type: Mast cell
Accession ID: CVCL_5G48
Organism: Human
Source: Blood CD34+ derived
Morphology: Suspension and adherent
Biosafety Level: BSL1
Subculturing: Cells can be split 1:2-1:5 depending on how often cells are needed for experiments.
Growth Conditions: StemPro-34 SFM (500mL), L-glutamine (2mM final), 5mL Pen Strep (10,000 U/mL), 1mL Primocin (50mg)
Cryopreservation: pZerve cryopreservative (Protide Pharmaceuticals)
Storage: Liquid nitrogen
Shipped: Dry ice
From the laboratory of John W. Steinke, PhD, Larry C. Borish, MD, and S. Brandon Early, University of Virginia.

A difference has been noted in how the cells are behaving that is different from the original publication. In the article, LUVA cells had high levels of expression of FceRI, however levels of around 5% by cell surface staining are currently being observed. Higher levels with intracellular staining are seen and very high mRNA expression for FceRI is detected. The reason for this difference is not clear.

  1. Laidlaw, T.M., Steinke, J.W., Tiñana, A.M., Xing, W.,Lam, B.K., Paruchuri, S., Boyce, J.A., and Borish, L. Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRI. Journal of Allergy and Clinical Immunology 127:815-822.e5 (2011)
  2. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott, LM and Metcalfe DD Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13) Blood 1999; 94,7: 2333-2342
  3. Johnson M, Alsaleh N, Mendoza RP, Persaud I, Bauer AK, Saba L, Brown JM. Genomic and transcriptomic comparison of allergen and silver nanoparticle-induced mast cell degranulation reveals novel non-immunoglobulin E mediated mechanisms. PLoS One. 2018 Mar 22;13(3):e0193499. View Article

If you publish research with this product, please let us know so we can cite your paper.